UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
July 30, 2019
Date of report (Date of earliest event reported)
IMAX Corporation
(Exact Name of Registrant as Specified in Its Charter)
| Canada |
1-35066 | 98-0140269 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) | ||
| 2525 Speakman Drive Mississauga, Ontario, Canada L5K 1B1 (905) 403-6500 |
902 Broadway, Floor 20 New York, New York, USA 10010 (212) 821-0100 | |||
(Address of principal executive offices, zip code, telephone numbers)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Common Shares, no par value | IMAX | The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Emerging Growth Company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition
On July 30, 2019, IMAX Corporation (the “Company”) issued a press release announcing the Company’s financial and operating results for the quarter ended June 30, 2019, a copy of which is attached as Exhibit 99.1.
The information in this current report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 |
||
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IMAX Corporation (Registrant) | ||||||
| Date: July 30, 2019 | By: | /s/ Richard L. Gelfond | ||||
| Name: | Richard L. Gelfond | |||||
| Title: | Chief Executive Officer & Director | |||||
3
Exhibit 99.1
IMAX CORPORATION
www.imax.com
IMAX CORPORATION REPORTS SECOND-QUARTER 2019 FINANCIAL RESULTS
HIGHLIGHTS
(Note: Percentage and other changes refer to second quarter 2018 unless otherwise noted.)
| · | Strong execution and focus on core business driving solid financial performance, with record results across key metrics for China business. |
| · | 6.6% growth in revenue driven by growth in global box office. |
| · | 10.0% growth in commercial network. |
| · | 28.8% growth in IMAX Greater China box office. |
| · | Delivered GAAP net income per share of $0.19, compared to $0.12; adjusted net income per share of $0.32, compared to $0.30 per share. |
| · | On-track to deliver low double-digit growth in IMAX global box office for full-year 2019. |
NEW YORK – Jul. 30, 2019 – IMAX Corporation (NYSE:IMAX), a world leader in using technology to eventicize content, reported revenues of $104.8 million, gross profit of $59.6 million and net income attributable to common shareholders of $11.4 million, or $0.19 per diluted share, for the second-quarter ended June 30, 2019. Adjusted net income attributable to common shareholders for the quarter was $19.7 million, or $0.32 per diluted share, Adjusted EBITDA was $41.4 million and Adjusted EBITDA margin was 43.8%. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA, please refer to Tables 8 - 10 and the discussion of non-GAAP measures at the end of this earnings release.
“IMAX is on track to deliver its best year ever at the box office, with the success of Spider-Man: Far From Home, The Lion King, and our record-breaking, first local language animated release in China this past weekend, Ne Zha, leading a strong second half film slate and building on our solid first-half,” said IMAX CEO Richard L. Gelfond. “Our continued success is driven by the privileged position we hold in the entertainment ecosystem, where our end-to-end technology empowers world-class creators to bring cultural events and communal experiences to life on a global scale.”
Second Quarter 2019 Results
Box Office Update (Table 2)
Gross box office from IMAX DMR® films was $364.9 million in the second quarter of 2019, compared to $342.6 million in the second quarter of 2018, representing an increase of 6.5%. The $22.3 million increase in gross box office was principally driven by a $29.1 million increase in China box office. A total of 19 films (15 new and 4 carryovers) were exhibited in the quarter, compared to 14 films (10 new and 4 carryovers) in the second quarter of 2018.
“Through our strong relationships with creators, the power of our global network and our continued cost discipline, we are now delivering top-line growth, EBITDA margin expansion and enhanced returns on capital for investors,” Gelfond added. “We continue to enhance IMAX’s position in the entertainment ecosystem and have established a solid foundation to deliver further growth in the quarters and years ahead.”
1
Global Network Update (Table 3)
The total IMAX® theater network consisted of 1,541 systems as of June 30, 2019, of which 1,445 were in commercial multiplexes. Including upgrades, there were 612 theaters in backlog as of June 30, 2019, compared to the 635 in backlog as of June 30, 2018.
IMAX also signed contracts for 54 new theaters and 19 upgrades in the second quarter of 2019, reflecting the strong demand for our systems. During the quarter, the Company installed 35 theater systems, 27 of which were for new theater locations. For a breakdown of theater system signings, backlog, installations, and network by type for the second quarter of 2019, please refer to Table 3 at the end of this earnings release.
Second Quarter Consolidated Results
The gross margin across all segments in the second quarter of 2019 was $59.6 million, or 56.8% of total revenues, compared to $60.4 million, or 61.4% of total revenues, in the second quarter of 2018. The slight decline in gross margin was driven by higher cost of revenues in our Network and Theater businesses, as well as a decline in revenues in our New Business segment as a result of a residual one-time payment to the Company of $2.6 million in the prior year period related to our discontinued virtual reality initiative. Operating expenses (which includes SG&A, excluding stock-based compensation, plus R&D) were $26.8 million in the quarter representing an 10.9% decline from the prior year period.
Second Quarter Segment Results (Table 1)
(in millions of USD except % change amounts)
| Network Business | Theater Business | |||||||||||
| Revenue | Gross Margin |
Gross Margin % |
Revenue | Gross Margin |
Gross Margin % | |||||||
|
| ||||||||||||
| 2Q19 |
$ 64.7 | $ 43.2 | 66.8% | $ 34.9 | $ 15.4 | 44.2% | ||||||
| 2Q18 |
60.9 | 42.9 | 70.5% | 30.9 | 16.0 | 51.9% | ||||||
| % change |
6.3% | 0.7% | 13.2% | (3.8%) | ||||||||
| YTD 2Q19 |
$ 110.6 | $ 74.8 | 67.7% | $ 65.2 | $ 28.6 | 43.9% | ||||||
| YTD 2Q18 |
105.8 | 74.4 | 70.3% | 65.8 | 36.5 | 55.4% | ||||||
| % change |
4.5% | 0.5% | (0.9%) | (21.5%) | ||||||||
Second Quarter Segment Results (Tables 1 and 7)
Network Business
| · | Network business revenues increased 6.3% to $64.7 million in the quarter, compared with $60.9 million in the prior-year period. The $3.8 million increase in revenues was driven principally by a $3.1 million, or 8.7%, increase in IMAX DMR revenues and a $0.6 million, or 2.3% increase in revenues from joint revenue-sharing arrangements. The strong increase in IMAX DMR revenues was driven by a $22.3 million increase in IMAX global box office. |
| · | The blended take-rate (defined as total Network revenue divided by total IMAX global box office) for IMAX DMR and joint revenue sharing arrangements was 17.7% in the quarter, compared to 17.8% in the prior year period. The slight decline is due to mix of global box office, including the strong performance of Greater China. |
| · | Gross margin for the Network business was 66.8%, compared to 70.5% in the prior-year period. The decline in gross margin for the business was due to higher contractual marketing costs driven by the strong performance of |
2
| Avengers: Endgame, as well as a 50% increase in the number of releases in the quarter from the 10 new films released in the prior year period. |
Theater Business
| · | Theater business segment revenues increased 13.2% to $34.9 million in the quarter, compared with $30.9 million in the prior year period. The $4.1 million increase in revenues was driven principally by the higher number of installations in the quarter, as well as higher maintenance revenue on our expanded commercial theater network, partially offset by lower financing revenue. The commercial theater network increased 10.0% to 1,445 commercial multiplex theaters in the current quarter. (Please refer to Table 3 for detail on our signings, installations and theater network at the end of this earnings release). |
| · | The average revenue per new theater system was $1.3 million, compared to $1.2 million in the prior year period. |
| · | Gross margin on sales and sales-type leases was 38.5% compared to 57.6% in the prior year period. The decline in gross margin is due principally to the mix of systems installed in the current quarter, compared to the prior year, as well as the Company’s decision to allocate additional resources to ensure the successful roll out and launch of its new IMAX with Laser® technology. For full-year 2019, the Company anticipates margins on sales type theaters to return to approximately 50%. |
Cash Balances and Outstanding Debt (Table 5)
Total cash and cash equivalents as of June 30, 2019 was $106.5 million, which includes $64.9 million held in the People’s Republic of China. Total bank indebtedness was $23.0 million as of June 30, 2019, including the impact of $2.0 million of deferred financing fees, and represented a decrease of $14.8 million from $37.8 million at December 31, 2018. As of June 30, 2019, $275.0 million is available under the $300.0 million credit facility in place due June 28, 2023.
Share Count and Capital Return
The weighted average diluted shares outstanding in second quarter 2019 declined 3.0% to 61.5 million, compared to 63.4 million in second quarter 2018, due to share repurchase activity. In the second quarter of 2019, a total of 87,769 shares were repurchased at an average price of $19.45 for a total value of $1.7 million. A total of $126.9 million is available under the outstanding share repurchase authorization, which expires on June 30, 2020. Total shares outstanding as of June 30, 2019 was 61.3 million.
Full-Year 2019 Guidance
IMAX’s guidance for full-year 2019 is as follows:
| · | IMAX global box office is expected to experience low double-digit growth compared to the $1,032.1 million recorded in full-year 2018. |
| · | Operating expenses, defined as selling, general and administrative expenses less stock-based compensation plus research and development costs are expected to be in-line with the $110.7 million recorded in full-year 2018. |
| · | The effective tax rate is expected to be approximately 23%. |
| · | Adjusted EBITDA margin is expected to be approximately 41% to 42%. |
| · | Total theater installations are expected in the range of 185 to 190, consisting of new theater installs of 140 to 145 systems and upgrades to IMAX with Laser of approximately 45 systems. New theater installs are heavily weighted toward the fourth quarter of 2019. |
| · | Total theaters equipped with IMAX with Laser are expected to grow to approximately 140 systems. |
Conference Call
The Company will host a conference call today at 4:30 PM ET to discuss its second quarter 2019 financial results. This call is being webcast by Nasdaq and can be accessed at investors.imax.com. To access the call via telephone, interested parties in the US and Canada should dial (888) 254-3590 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 794-4605. The conference ID for the call is 2957384. A replay of the call will be
3
available via webcast at investors.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 2957384.
Supplemental Materials
For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.
Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag. In addition, the Company maintains a Twitter account: @IMAX_Investors. The Company intends to use Twitter to disclose the box office information, as well as other information that may be of interest to the Company’s investor community.
The information posted on the Company’s website and/or via its Twitter account may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website and its Twitter account in addition to the Company’s earnings releases, SEC filings and public conference calls and webcasts.
About IMAX Corporation
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.
IMAX is headquartered in New York, Toronto and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of June 30, 2019, there were 1,541 IMAX theater systems (1,445 commercial multiplexes, 15 commercial destinations, 81 institutional) operating in 81 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code “HK.1970.”
IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).
For additional information please contact:
| Investors: IMAX Corporation, New York Stephen Davidson 212-821-0125 sdavidson@imax.com
|
Media: IMAX Corporation, New York Mark Jafar 212-821-0102 mjafar@imax.com
| |
###
4
Forward-Looking Statements
This earnings release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the performance of IMAX DMR films; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company’s inability to protect the Company’s intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from any of the Company’s restructuring initiatives; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Primary Reporting Groups
The Company has four primary reporting groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment; (3) New Business, which includes home entertainment, and other new business initiatives that are in the development, start-up and/or wind-up phases, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.
Non-GAAP Financial Measures
In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility and free cash flow as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) and non-recurring charges on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort
5
the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) and non-recurring charges in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.
The Company is required to maintain a minimum level of “EBITDA”, as such term is defined in the Company’s credit agreement (and which is referred to herein as “Adjusted EBITDA per Credit Facility”, as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). EBITDA and Adjusted EBITDA per Credit Facility (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP. The Company believes that EBITDA and Adjusted EBITDA per Credit Facility are relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry.
Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the condensed consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented in Table 6.
Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended June 30, 2019 vs. 2018
The Company reported net income of $13.8 million, or $0.22 per basic and diluted share, for the second quarter of 2019 as compared to net income of $10.3 million, or $0.16 per basic and diluted share, for the second quarter of 2018.
Net income for the second quarter of 2019 includes a $7.0 million charge, or $0.11 per diluted share (2018— $6.8 million or $0.10 per diluted share), for stock-based compensation and a loss of $4.5 million, or $0.07 per diluted share, for the change in fair value of equity investment (2018 — $nil). The second quarter of 2018 also includes a $0.5 million charge, or $0.01 per diluted share, for exit costs, restructuring charges and associated impairments and a $7.5 million charge, or $0.12 per diluted share, for a legal arbitration award related to one of the Company’s litigation matters from 2006.
Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award, the change in fair value of equity investment and the related tax impact of these adjustments, was $23.8 million, or $0.38 per diluted share, for the second quarter of 2019 as compared to adjusted net income of $21.7 million, or $0.34 per diluted share, for the second quarter of 2018.
The Company reported net income attributable to common shareholders of $11.4 million, or $0.19 per basic and diluted share for the second quarter of 2019 (2018 — $7.6 million, or $0.12 per basic and diluted share).
Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award, the change in fair value of equity investment and the related tax impact of these adjustments, was $19.7 million, or $0.32 per diluted share, for the second quarter of 2019 as compared to adjusted net income attributable to common shareholders of $19.0 million, or $0.30 per diluted share, for the second quarter of 2018.
A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in Table 4.
6
Adjusted Net Income and Adjusted Diluted Per Share Calculations – Six Months Ended June 30, 2019 vs. 2018
The Company reported net income of $26.3 million, or $0.43 per basic and diluted share, for the six months ended June 30, 2019 as compared to net income of $22.3 million, or $0.35 per basic and diluted share, for the six months ended June 30, 2018.
Net income for the six months ended June 30, 2019, includes a $11.4 million charge, or $0.19 per diluted share (2018 — $11.6 million or $0.18 per diluted share), for stock-based compensation, a $0.9 million charge, or $0.01 per diluted share for exit costs, restructuring charges and associated impairments (2018 — $1.2 million, or $0.02 per diluted share) and a loss of $2.1 million, or $0.03 per diluted share, for the change in fair value of equity investment (2018 — $nil). The six months ended June 30, 2018 includes a $7.5 million charge, or $0.12 per diluted share, for a legal arbitration award related to one of the Company’s litigation matters from 2006.
Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award, the change in fair value of equity investment and the related tax impact of these adjustments, was $38.1 million, or $0.62 per diluted share, for the six months ended June 30, 2019, as compared to adjusted net income of $38.8 million, or $0.61 per diluted share, for the six months ended June 30, 2018.
The Company reported net income attributable to common shareholders of $19.7 million, or $0.32 per basic and diluted share for the six months ended June 30, 2019 (2018 — $16.1 million, or $0.25 per basic and diluted share).
Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award, the change in fair value of equity investment and the related tax impact of these adjustments, was $30.5 million, or $0.49 per diluted share, for the six months ended June 30, 2019, as compared to adjusted net income attributable to common shareholders of $32.4 million, or $0.51 per diluted share, for the six months ended June 30, 2018.
A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in Table 4.
Table 2:
IMAX Global Box Office
| (in millions of USD) | For the three months ended, | |||||||||||||||||||||||
| Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2018 | Sept. 30, 2018 | Jun. 30, 2018 | ||||||||||||||||||||
|
|
|
|||||||||||||||||||||||
| Domestic |
$ | 123.3 | $ | 71.8 | $ | 82.1 | $ | 62.0 | $ | 131.2 | ||||||||||||||
| Greater China |
130.1 | 105.8 | 69.2 | 77.8 | 101.0 | |||||||||||||||||||
| Rest of World |
111.5 | 78.7 | 85.4 | 66.7 | 110.4 | |||||||||||||||||||
|
|
|
|||||||||||||||||||||||
| Total Global Box Office |
364.9 | 256.3 | 236.7 | 206.5 | 342.6 | |||||||||||||||||||
7
Table 3:
Signings and Installations
| Three Months Ended June 30, |
||||||||
| Theater System Signings: | 2019 | 2018 | ||||||
| Full new sales and sales-type lease arrangements |
7 | 9 | ||||||
| New traditional joint revenue sharing arrangements |
2 | 31 | ||||||
| New hybrid joint revenue sharing lease arrangements |
45 | - | ||||||
|
|
|
|
|
|||||
| Total new theaters |
54 | 40 | ||||||
| Upgrades of IMAX theater systems |
19 | 98 | ||||||
|
|
|
|
|
|||||
| Total theater signings |
73 | 138 | ||||||
|
|
|
|
|
|||||
| Three Months Ended June 30, |
||||||||
| Theater System Installations: | 2019 | 2018 | ||||||
| Full new sales and sales-type lease arrangements |
9 | 9 | ||||||
| New traditional joint revenue sharing arrangements |
13 | 19 | ||||||
| New hybrid joint revenue sharing lease arrangements |
5 | 2 | ||||||
|
|
|
|
|
|||||
| Total new theaters |
27 | 30 | ||||||
| Upgrades of IMAX theater systems |
8 | 1 | ||||||
|
|
|
|
|
|||||
| Total theater installations |
35 | 31 | ||||||
|
|
|
|
|
|||||
| Three Months Ended June 30, |
||||||||
| Theater Sales Backlog: | 2019 | 2018 | ||||||
| Sales and sales-type lease arrangements |
182 | 181 | ||||||
| Joint revenue sharing arrangements |
||||||||
| Hybrid lease arrangements |
154 | 115 | ||||||
| Traditional arrangements |
276 | (1) | 339 | |||||
|
|
|
|
|
|||||
| Total theater backlog |
612 | (2) | 635 | (3) | ||||
|
|
|
|
|
|||||
| Three Months Ended June 30, |
||||||||
| Theater Network: | 2019 | 2018 | ||||||
| Commercial Multiplex Theaters: |
||||||||
| Sales and sales-type lease arrangements |
619 | 576 | ||||||
| Traditional joint revenue sharing arrangements |
693 | 628 | ||||||
| Hybrid joint revenue sharing lease arrangements |
133 | 110 | ||||||
|
|
|
|
|
|||||
| Total Commercial Multiplex Theaters |
1,445 | 1,314 | ||||||
| Commercial Destination Theaters |
15 | 12 | ||||||
| Institutional Theaters |
81 | 84 | ||||||
|
|
|
|
|
|||||
| Total theater network |
1,541 | 1,410 | ||||||
|
|
|
|
|
|||||
| (1) | Includes 60 theater systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement. |
| (2) | Includes 150 new laser projection system configurations and 121 upgrades of existing locations to laser projection system configurations (118 of the 121 upgrades are for the IMAX with Laser projection system configurations). |
| (3) | Includes 75 new laser projection system configurations and 101 upgrades of existing locations to laser projection system configurations (99 of the 101 upgrades are for the IMAX with Laser projection system configurations). |
8
Table 4:
IMAX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts)
(Unaudited)
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2019 | 2018 | 2019 | 2018 | |||||||||||||
| Revenues |
||||||||||||||||
| Equipment and product sales |
$ | 19,694 | $ | 15,368 | $ | 34,894 | $ | 34,881 | ||||||||
| Services |
56,662 | 54,785 | 100,809 | 99,531 | ||||||||||||
| Rentals |
25,863 | 25,124 | 44,033 | 43,326 | ||||||||||||
| Finance income |
2,578 | 3,068 | 5,259 | 5,591 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| 104,797 | 98,345 | 184,995 | 183,329 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Costs and expenses applicable to revenues |
||||||||||||||||
| Equipment and product sales |
11,939 | 7,549 | 21,374 | 15,521 | ||||||||||||
| Services |
26,781 | 23,633 | 46,024 | 43,984 | ||||||||||||
| Rentals |
6,524 | 6,759 | 12,904 | 12,728 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| 45,244 | 37,941 | 80,302 | 72,233 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Gross margin |
59,553 | 60,404 | 104,693 | 111,096 | ||||||||||||
| Selling, general and administrative expenses |
32,136 | 32,484 | 59,785 | 60,443 | ||||||||||||
| Research and development |
1,222 | 3,922 | 2,358 | 7,514 | ||||||||||||
| Amortization of intangibles |
1,218 | 965 | 2,293 | 1,857 | ||||||||||||
| Receivable provisions, net of recoveries |
927 | 355 | 1,358 | 806 | ||||||||||||
| Legal arbitration award |
- | 7,500 | - | 7,500 | ||||||||||||
| Exit costs, restructuring charges and associated impairments |
- | 456 | 850 | 1,158 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Income from operations |
24,050 | 14,722 | 38,049 | 31,818 | ||||||||||||
| Change in fair value of equity investment |
(4,544 | ) | - | (2,053 | ) | - | ||||||||||
| Retirement benefits non-service expense |
(160 | ) | (124 | ) | (320 | ) | (248 | ) | ||||||||
| Interest income |
572 | 243 | 1,142 | 490 | ||||||||||||
| Interest expense |
(636 | ) | (851 | ) | (1,317 | ) | (1,345 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Income before income taxes |
19,282 | 13,990 | 35,501 | 30,715 | ||||||||||||
| Provision for income taxes |
(5,308 | ) | (3,635 | ) | (8,956 | ) | (8,088 | ) | ||||||||
| Loss from equity-accounted investments, net of tax |
(138 | ) | (100 | ) | (222 | ) | (305 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Net income |
13,836 | 10,255 | 26,323 | 22,322 | ||||||||||||
| Less: net income attributable to non-controlling interests |
(2,439 | ) | (2,630 | ) | (6,661 | ) | (6,192 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Net income attributable to common shareholders |
$ | 11,397 | $ | 7,625 | $ | 19,662 | $ | 16,130 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Net income per share attributable to common shareholders - basic and diluted: |
|
|||||||||||||||
| Net income per share — basic and diluted |
$ | 0.19 | $ | 0.12 | $ | 0.32 | $ | 0.25 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Weighted average number of shares outstanding (000’s): |
||||||||||||||||
| Basic |
61,331 | 63,314 | 61,354 | 63,931 | ||||||||||||
| Fully Diluted |
61,507 | 63,426 | 61,525 | 64,006 | ||||||||||||
| Additional Disclosure: |
||||||||||||||||
| Depreciation and amortization(1) |
$ | 15,593 | $ | 14,513 | $ | 29,804 | $ | 28,034 | ||||||||
| (1) Includes $0.1 million and $0.2 million of amortization of deferred financing costs charged to interest expense for the three and six months ended June 30, 2019, respectively (2018 - $0.4 million and $0.6 million, respectively). |
| |||||||||||||||
9
Table 5:
IMAX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars)
(Unaudited)
| June 30, | December 31, | |||||||
| 2019 | 2018 | |||||||
| Assets |
||||||||
| Cash and cash equivalents |
$ | 106,451 | $ | 141,590 | ||||
| Accounts receivable, net of allowance for doubtful accounts of $4,641 (December 31, 2018 — $3,174) |
91,490 | 93,309 | ||||||
| Financing receivables, net of allowance for uncollectible amounts |
121,649 | 127,432 | ||||||
| Variable consideration receivable from contracts |
36,347 | 35,985 | ||||||
| Inventories |
47,976 | 44,560 | ||||||
| Prepaid expenses |
11,447 | 10,294 | ||||||
| Film assets |
17,266 | 16,367 | ||||||
| Property, plant and equipment |
308,326 | 280,658 | ||||||
| Investment in equity securities |
14,149 | 1,022 | ||||||
| Other assets |
19,946 | 17,997 | ||||||
| Deferred income taxes |
29,638 | 31,264 | ||||||
| Other intangible assets |
32,176 | 34,095 | ||||||
| Goodwill |
39,027 | 39,027 | ||||||
|
|
|
|
|
|
| |||
| Total assets |
$ | 875,888 | $ | 873,600 | ||||
|
|
|
|
|
|
| |||
| Liabilities |
||||||||
| Bank indebtedness |
$ | 22,976 | $ | 37,753 | ||||
| Accounts payable |
22,155 | 32,057 | ||||||
| Accrued and other liabilities |
114,150 | 97,724 | ||||||
| Deferred revenue |
105,384 | 106,709 | ||||||
|
|
|
|
|
|
| |||
| Total liabilities |
264,665 | 274,243 | ||||||
|
|
|
|
|
|
| |||
| Commitments and contingencies |
||||||||
| Non-controlling interests |
7,172 | 6,439 | ||||||
|
|
|
|
|
|
| |||
| Shareholders’ equity |
||||||||
| Capital stock common shares — no par value. Authorized — unlimited number. 61,432,275 issued and 61,331,289 outstanding (December 31, 2018 — 61,478,168 issued and 61,433,589 outstanding) |
423,676 | 422,455 | ||||||
| Less: Treasury stock, 77,607 shares at cost (December 31, 2018 — 44,579) |
(1,575 | ) | (916 | ) | ||||
| Other equity |
166,232 | 179,595 | ||||||
| Accumulated deficit |
(66,828 | ) | (85,385 | ) | ||||
| Accumulated other comprehensive loss |
(2,926 | ) | (3,588 | ) | ||||
|
|
|
|
|
|
| |||
| Total shareholders’ equity attributable to common shareholders |
518,579 | 512,161 | ||||||
| Non-controlling interests |
85,472 | 80,757 | ||||||
|
|
|
|
|
|
| |||
| Total shareholders’ equity |
604,051 | 592,918 | ||||||
|
|
|
|
|
|
| |||
| Total liabilities and shareholders’ equity |
$ | 875,888 | $ | 873,600 | ||||
|
|
|
|
|
|
| |||
10
Table 6:
| IMAX CORPORATION | ||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
| (In thousands of U.S. dollars) | ||||
| (Unaudited) | ||||
| Six Months Ended | ||||||||
| June 30, | ||||||||
| 2019 | 2018 | |||||||
| Cash provided by (used in): |
||||||||
| Operating Activities |
||||||||
| Net income |
$ | 26,323 | $ | 22,322 | ||||
| Adjustments to reconcile net income to cash from operations: |
||||||||
| Depreciation and amortization |
29,804 | 28,034 | ||||||
| Write-downs, net of recoveries |
1,866 | 1,686 | ||||||
| Change in deferred income taxes |
1,296 | 347 | ||||||
| Stock and other non-cash compensation |
11,710 | 11,920 | ||||||
| Unrealized foreign currency exchange (gain) loss |
(14 | ) | 473 | |||||
| Change in fair value of equity investment |
2,053 | - | ||||||
| Loss from equity-accounted investments |
421 | 106 | ||||||
| (Gain) loss on non-cash contribution to equity-accounted investees |
(199 | ) | 199 | |||||
| Investment in film assets |
(8,214 | ) | (18,219 | ) | ||||
| Changes in other non-cash operating assets and liabilities |
(16,529 | ) | (214 | ) | ||||
|
|
|
|
|
|
| |||
| Net cash provided by operating activities |
48,517 | 46,654 | ||||||
|
|
|
|
|
|
| |||
| Investing Activities |
||||||||
| Purchase of property, plant and equipment |
(4,175 | ) | (8,632 | ) | ||||
| Investment in joint revenue sharing equipment |
(22,235 | ) | (8,455 | ) | ||||
| Acquisition of other intangible assets |
(1,121 | ) | (1,705 | ) | ||||
| Investment in equity securities |
(15,153 | ) | - | |||||
|
|
|
|
|
|
| |||
| Net cash used in investing activities |
(42,684 | ) | (18,792 | ) | ||||
|
|
|
|
|
|
| |||
| Financing Activities |
||||||||
| Increase in bank indebtedness |
35,000 | - | ||||||
| Repayment of bank indebtedness |
(50,000 | ) | (1,000 | ) | ||||
| Settlement of restricted share units and options |
(7,619 | ) | (1,529 | ) | ||||
| Treasury stock purchased for future settlement of restricted share units |
(1,575 | ) | (4,636 | ) | ||||
| Repurchase of common shares, IMAX China |
(16,813 | ) | - | |||||
| Taxes withheld and paid on employee stock awards vested |
(219 | ) | (1,279 | ) | ||||
| Common shares issued - stock options exercised |
2,379 | 799 | ||||||
| Repurchase of common shares |
(1,258 | ) | (46,452 | ) | ||||
| Issuance of subsidiary shares to non-controlling interests (net of return on capital) |
1,106 | 6,696 | ||||||
| Dividends paid to non-controlling interests |
(2,266 | ) | (4,623 | ) | ||||
| Credit facility amendment fees paid |
- | (1,963 | ) | |||||
|
|
|
|
|
|
| |||
| Net cash used in financing activities |
(41,265 | ) | (53,987 | ) | ||||
|
|
|
|
|
|
| |||
| Effects of exchange rate changes on cash |
293 | 442 | ||||||
|
|
|
|
|
|
| |||
| Decrease in cash and cash equivalents during period |
(35,139 | ) | (25,683 | ) | ||||
| Cash and cash equivalents, beginning of period |
|
141,590
|
|
|
158,725
|
| ||
|
|
|
|
|
|
| |||
| Cash and cash equivalents, end of period |
$ | 106,451 | $ | 133,042 | ||||
|
|
|
|
|
|
| |||
11
Table 7:
IMAX CORPORATION
SELECTED FINANCIAL DATA
In accordance with United States Generally Accepted Accounting Principles
(in thousands of U.S. dollars)
| Three Months Ended | ||||||||
| June 30, | ||||||||
|
|
|
| ||||||
| 2019 | 2018 | |||||||
| Revenue |
||||||||
| Network Business |
||||||||
| IMAX DMR |
$ | 39,293 | $ | 36,161 | ||||
| Joint revenue sharing arrangements – contingent rent |
25,301 | 24,730 | ||||||
| IMAX systems – contingent rent |
131 | - | ||||||
|
|
|
|
|
|
| |||
| 64,725 | 60,891 | |||||||
|
|
|
|
|
|
| |||
| Theater Business |
||||||||
| IMAX systems |
||||||||
| Sales and sales-type leases |
13,793 | 11,981 | ||||||
| Ongoing fees and finance income |
2,816 | 3,282 | ||||||
| Joint revenue sharing arrangements – fixed fees |
2,548 | 1,022 | ||||||
| Theater system maintenance |
13,207 | 12,335 | ||||||
| Other theater |
2,580 | 2,255 | ||||||
|
|
|
|
|
|
| |||
| 34,944 | 30,875 | |||||||
|
|
|
|
|
|
| |||
| New Business |
478 | 3,116 | ||||||
|
|
|
|
|
|
| |||
| Other |
||||||||
| Film distribution and post-production |
3,601 | 2,360 | ||||||
| Other |
1,049 | 1,103 | ||||||
|
|
|
|
|
|
| |||
| 4,650 | 3,463 | |||||||
|
|
|
|
|
|
| |||
| Total |
$ | 104,797 | $ | 98,345 | ||||
|
|
|
|
|
|
| |||
| Gross margin |
||||||||
| Network Business |
||||||||
| IMAX DMR(1) |
$ | 23,961 | $ | 24,280 | ||||
| Joint revenue sharing arrangements – contingent rent(1) |
19,128 | 18,621 | ||||||
| IMAX systems – contingent rent |
131 | - | ||||||
|
|
|
|
|
|
| |||
| 43,220 | 42,901 | |||||||
|
|
|
|
|
|
| |||
| Theater Business |
||||||||
| IMAX systems(1) |
||||||||
| Sales and sales-type leases |
5,310 | 6,899 | ||||||
| Ongoing fees and finance income |
2,768 | 3,234 | ||||||
| Joint revenue sharing arrangements – fixed fees(1) |
870 | 246 | ||||||
| Theater system maintenance |
5,640 | 5,088 | ||||||
| Other theater |
841 | 563 | ||||||
|
|
|
|
|
|
| |||
| 15,429 | 16,030 | |||||||
|
|
|
|
|
|
| |||
| New Business |
281 | 1,906 | ||||||
|
|
|
|
|
|
| |||
| Other |
||||||||
| Film distribution and post-production(1) |
458 | (387 | ) | |||||
| Other |
165 | (46 | ) | |||||
|
|
|
|
|
|
| |||
| 623 | (433 | ) | ||||||
|
|
|
|
|
|
| |||
| Total |
$ | 59,553 | $ | 60,404 | ||||
|
|
|
|
|
|
| |||
12
| (1) | IMAX DMR segment margins include marketing costs of $9.5 million and $13.4 million for the three and six months ended June 30, 2019, respectively (2018 - $6.5 million and $10.6 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.2 million and $0.3 million for the three and six months ended June 30, 2019, respectively (2018 - $1.0 million and $1.2 million, respectively). IMAX system segment margins include marketing and commission costs of $0.4 million and $0.9 million for the three and six months ended June 30, 2019, respectively (2018 - $0.5 million and $1.2 million, respectively). Film distribution and post production segment margins include marketing expense of $0.1 million and $0.6 for the three and six months ended June 30, 2019, respectively (2018 - an expense of $0.8 million and $2.0 million, respectively). |
Table 8:
IMAX CORPORATION
Adjusted EBITDA per Credit Facility
(in thousands of U.S. dollars)
| For the | For the | |||||||
|
3 Months Ended |
12 Months Ended |
|||||||
|
June 30, 2019 |
June 30, 2019 (1) |
|||||||
| (In thousands of U.S. Dollars) |
||||||||
| Net income |
$ | 13,836 | $ | 37,596 | ||||
| Add (subtract): |
||||||||
| Provision for income taxes |
5,308 | 10,386 | ||||||
| Interest expense, net of interest income |
64 | 392 | ||||||
| Depreciation and amortization, including film asset amortization |
15,593 | 59,207 | ||||||
|
|
|
|
|
|||||
| EBITDA |
$ | 34,801 | $ | 107,581 | ||||
| Stock and other non-cash compensation |
7,186 | 23,513 | ||||||
| Change in fair value of equity investment |
4,544 | 2,053 | ||||||
| Write-downs, net of recoveries including asset impairments and receivable provisions |
1,169 | 5,518 | ||||||
| Exit costs, restructuring charges and associated impairments |
- | 9,234 | ||||||
| Legal arbitration award |
- | 4,237 | ||||||
| Executive transition costs |
- | 2,994 | ||||||
| Loss from equity accounted investments |
138 | 409 | ||||||
|
|
|
|
|
|||||
| Adjusted EBITDA before non-controlling interests |
$ | 47,838 | $ | 155,539 | ||||
| Adjusted EBITDA attributable to non-controlling interests(2) |
(6,418) | (23,398) | ||||||
|
|
|
|
|
|||||
| Adjusted EBITDA per Credit Facility |
$ | 41,420 | $ | 132,141 | ||||
|
|
|
|
|
|||||
| Adjusted revenues attributable to common shareholders (3) |
$ | 94,581 | $ | 336,162 | ||||
|
|
|
|
|
|||||
| Adjusted EBITDA margin |
43.8 | % | 39.3 | % | ||||
|
|
|
|
|
|||||
| (1) Senior Secured Net Leverage Ratio calculated using twelve months ended Adjusted EBITDA per Credit Facility. |
| |||||||
|
(2) The Adjusted EBITDA per Credit Facility calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the Company’s non-controlling interests. |
| |||||||
| (3) | 3 months ended June 30, 2019 | 12 months ended June 30, 2019 | ||||||||||||||
| Total revenues |
$ | 104,797 | $ | 376,067 | ||||||||||||
| Greater China revenues |
$ | 32,575 | $ | 125,289 | ||||||||||||
| Non-controlling interest ownership percentage(4) |
31.36% | 31.85% | ||||||||||||||
|
|
|
|
|
|||||||||||||
| Deduction for non-controlling interest share of revenues |
(10,216) | (39,905) | ||||||||||||||
|
|
|
|
|
|||||||||||||
| Adjusted revenues attributable to common shareholders |
$ | 94,581 | $ | 336,162 | ||||||||||||
|
|
|
|
|
|||||||||||||
| (4) Weighted average ownership percentage for change in non-controlling interest share |
| |||||||||||||||
13
Table 9:
IMAX CORPORATION
Adjusted Net Income and Adjusted Diluted Per Share Calculations
(in thousands of U.S. dollars)
| Quarter Ended June 30, | ||||||||||||||||
| (In thousands of U.S. dollars, except per share amounts) |
2019 |
2018 | ||||||||||||||
| Net Income
|
Diluted EPS
|
Net Income
|
Diluted EPS
| |||||||||||||
| Reported net income |
$ |
13,836 |
|
$ |
0.22 |
|
$ |
10,255 |
|
$ |
0.16 |
| ||||
| Adjustments: |
||||||||||||||||
| Stock-based compensation |
7,027 | 0.11 | 6,756 | 0.10 | ||||||||||||
| Exit costs, restructuring charges and associated impairments |
- | - | 456 | 0.01 | ||||||||||||
| Legal arbitration award |
- | - | 7,500 | 0.12 | ||||||||||||
| Change in fair value of equity investment |
4,544 | 0.07 | - | - | ||||||||||||
| Tax impact on items listed above |
(1,655 | ) | (0.02 | ) | (3,228 | ) | (0.05 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Adjusted net income |
23,752 | 0.38 | 21,739 | 0.34 | ||||||||||||
| Net income attributable to non-controlling interests(1) |
(2,439 | ) | (0.04 | ) | (2,630 | ) | (0.04 | ) | ||||||||
| Stock-based compensation (net of tax of less than $0.1 million and less than $0.1 million, respectively)(1) |
(177 | ) | - | (147 | ) | - | ||||||||||
| Change in fair value of equity investment(1) |
(1,443 | ) | (0.02 | ) | - | - | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Adjusted net income attributable to common shareholders |
$ | 19,693 | $ | 0.32 | $ | 18,962 | $ | 0.30 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Weighted average diluted shares outstanding |
61,507 | 63,426 | ||||||||||||||
|
|
|
|
|
|
| |||||||||||
| Six Months Ended June 30, | ||||||||||||||||
| (In thousands of U.S. dollars, except per share amounts) |
2019 |
2018 | ||||||||||||||
| Net Income
|
Diluted EPS
|
Net Income
|
Diluted EPS
| |||||||||||||
| Reported net income |
$ |
26,323 |
|
$ |
0.43 |
|
$ |
22,322 |
|
$ |
0.35 |
| ||||
| Adjustments: |
||||||||||||||||
| Stock-based compensation |
11,389 | 0.19 | 11,603 | 0.18 | ||||||||||||
| Exit costs, restructuring charges and associated impairments |
850 | 0.01 | 1,158 | 0.02 | ||||||||||||
| Legal arbitration award |
- | - | 7,500 | 0.12 | ||||||||||||
| Change in fair value of equity investment |
2,053 | 0.03 | - | - | ||||||||||||
| Tax impact on items listed above |
(2,535 | ) | (0.04 | ) | (3,787 | ) | (0.06 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Adjusted net income |
38,080 | 0.62 | 38,796 | 0.61 | ||||||||||||
| Net income attributable to non-controlling interests(1) |
(6,661 | ) | (0.12 | ) | (6,192 | ) | (0.10 | ) | ||||||||
| Stock-based compensation (net of tax of $0.1 million and $0.1 million, respectively) (1) |
(262 | ) | - | (204 | ) | - | ||||||||||
| Change in fair value of equity investment(1) |
(652 | ) | (0.01 | ) | - | - | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Adjusted net income attributable to common shareholders |
$ | 30,505 | $ | 0.49 | $ | 32,400 | $ | 0.51 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| Weighted average diluted shares outstanding |
61,525 | 64,006 | ||||||||||||||
|
|
|
|
|
|
| |||||||||||
| (1) | Reflects amounts attributable to non-controlling interests. |
14
Table 10:
IMAX CORPORATION
Free Cash Flow Calculation
(in thousands of U.S. dollars)
| For the | For the | |||||||
| Three months ended | Six months ended | |||||||
| June 30, 2019 | June 30, 2019 | |||||||
| (In thousands of U.S. Dollars) | ||||||||
| Net cash provided by operating activities |
$ | 49,186 | $ | 48,517 | ||||
| Net cash used in investing activities |
(15,038 | ) | (42,684 | ) | ||||
|
|
|
|
|
|
| |||
| Net free cash flow |
$ | 34,148 | $ | 5,833 | ||||
|
|
|
|
|
|
| |||
15